↓ Skip to main content

The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease

Overview of attention for article published in Lipids in Health and Disease, January 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter
4 tweeters
video
1 video uploader

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease
Published in
Lipids in Health and Disease, January 2010
DOI 10.1186/1476-511x-9-119
Pubmed ID
Authors

Igor A Sobenin, Valentin V Pryanishnikov, Lyudmila M Kunnova, Yevgeny A Rabinovich, Danik M Martirosyan, Alexander N Orekhov

Abstract

The double-blinded placebo-controlled randomized study has been performed in 51 coronary heart disease (CHD) patients to estimate the effects of time-released garlic powder tablets Allicor on the values of 10-year prognostic risk of acute myocardial infarction (fatal and non-fatal) and sudden death, with the respect of secondary CHD prevention. It has been demonstrated that 12-month treatment with Allicor results in the significant decrease of cardiovascular risk by 1.5-fold in men (p < 0.05), and by 1.3-fold in women. The above results were equitable also in terms of relative risks. The main effect that played a role in cardiovascular risk reduction was the decrease in LDL cholesterol by 32.9 mg/dl in men (p < 0.05), and by 27.3 mg/dl in women. Thus, the most significant effects were observed in men, while in women the decrease of cardiovascular risk appeared as a trend that might be due presumably to the insufficient sample size. Since Allicor is the remedy of natural origin, it is safe with the respect to adverse effects and allows even perpetual administration that may be crucial for the secondary prevention of atherosclerotic diseases in CHD patients.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
United Kingdom 2 2%
Brazil 1 1%
Unknown 80 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 26%
Student > Master 17 20%
Other 12 14%
Researcher 11 13%
Student > Postgraduate 7 8%
Other 15 18%
Unknown 1 1%
Readers by discipline Count As %
Medicine and Dentistry 26 31%
Agricultural and Biological Sciences 17 20%
Biochemistry, Genetics and Molecular Biology 11 13%
Nursing and Health Professions 9 11%
Unspecified 7 8%
Other 14 16%
Unknown 1 1%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2019.
All research outputs
#3,893,826
of 13,500,585 outputs
Outputs from Lipids in Health and Disease
#267
of 969 outputs
Outputs of similar age
#51,087
of 187,557 outputs
Outputs of similar age from Lipids in Health and Disease
#1
of 1 outputs
Altmetric has tracked 13,500,585 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 969 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them